Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$52,203,940
-$4,212,617 QoQ
Shares Held
413,202
+2.1% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#204
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $1,560,895,629 across 16 Drug Manufacturers - General names. GILD ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
366,026 | $439,022,601 | |
| 2 | JNJ |
Johnson & Johnson
|
1,094,399 | $277,944,514 | |
| 3 | ABBV |
AbbVie Inc.
|
990,692 | $249,297,734 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,229,081 | $157,936,908 | |
| 5 | AMGN |
Amgen Inc
|
333,544 | $120,782,953 | |
| 6 | PFE |
Pfizer Inc
|
3,183,708 | $76,663,688 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
413,202 | $52,203,940 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
883,910 | $50,930,894 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,203,940 | 413,202 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $56,416,557 | 404,797 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $50,027,105 | 407,586 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $43,309,980 | 390,180 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $29,413,700 | 265,299 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $27,265,462 | 243,333 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $21,239,927 | 229,944 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,565,405 | 233,366 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $14,936,534 | 217,702 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $15,668,248 | 213,901 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $7,614,291 | 93,992 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,562,345 | 87,568 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,992,792 | 90,733 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $8,092,064 | 97,530 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,670,334 | 100,994 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,869,073 | 62,718 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,146,338 | 67,082 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,446,138 | 57,967 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,854,864 | 53,090 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,093,322 | 72,918 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $5,138,884 | 74,628 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,932,412 | 60,845 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,629,164 | 79,457 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $304,765 | 4,823 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $416,091 | 5,408 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,002,755 | 13,413 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||